Paul M Loadman

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Pharmaceutics

Nature

BMJ open

Cancer prevention research (Philadelphia, Pa.)

University of Bradford

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Bradford

United Kingdom

Professor of Drug Metabolism and Pharmacokinetics :: Institute of Cancer Therapeutics

Publications

Nicola Ingram, Radwa H Abou-Saleh, Amanda D Race, Paul M Loadman, Richard J Bushby, Stephen D Evans, P Louise Coletta
Maleimide-Thiol Linkages Alter the Biodistribution of SN38 Therapeutic Microbubbles Compared to Biotin-Avidin While Preserving Parity in Tumoral Drug Delivery. Pharmaceutics 16 (3) (2024)
Nicola Ingram, Radwa H Abou-Saleh, Amanda D Race, Paul M Loadman, Richard J Bushby, Stephen D Evans, P Louise Coletta
Maleimide-Thiol Linkages Alter the Biodistribution of SN38 Therapeutic Microbubbles Compared to Biotin-Avidin While Preserving Parity in Tumoral Drug Delivery. Pharmaceutics 16 (3) (2024)
Nicola Ingram, Radwa H Abou-Saleh, Amanda D Race, Paul M Loadman, Richard J Bushby, Stephen D Evans, P Louise Coletta
Maleimide-Thiol Linkages Alter the Biodistribution of SN38 Therapeutic Microbubbles Compared to Biotin-Avidin While Preserving Parity in Tumoral Drug Delivery. Pharmaceutics 16 (3) (2024)
Nicola Ingram, Radwa H Abou-Saleh, Amanda D Race, Paul M Loadman, Richard J Bushby, Stephen D Evans, P Louise Coletta
Maleimide-Thiol Linkages Alter the Biodistribution of SN38 Therapeutic Microbubbles Compared to Biotin-Avidin While Preserving Parity in Tumoral Drug Delivery. Pharmaceutics 16 (3) (2024)
John R Davies, Tracey Mell, Harriett Fuller, Mark Harland, Rasha Noureldin M Saleh, Amanda D Race, Colin J Rees, Louise C Brown, Paul M Loadman, Amy Downing, Anne Marie Minihane, Elizabeth A Williams, Mark A Hull
Polymorphisms in Cyclooxygenase, Lipoxygenase and TP53 genes predict colorectal polyp risk reduction by aspirin in the seAFOod polyp prevention trial. Cancer prevention research (Philadelphia, Pa.) (2023)
Mark A Hull, Pei Loo Ow, Sharon Ruddock, Tim Brend, Alexandra F Smith, Helen Marshall, Mingyang Song, Andrew T Chan, Wendy S Garrett, Omer Yilmaz, David A Drew, Fiona Collinson, Andrew J Cockbain, Robert Jones, Paul M Loadman, Peter S Hall, Catherine Moriarty, David A Cairns, Giles J Toogood
Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol. BMJ open 13 (11) (2023)
Simon Eschweiler, Ciro Ramírez-Suástegui, Yingcong Li, Emma King, Lindsey Chudley, Jaya Thomas, Oliver Wood, Adrian von Witzleben, Danielle Jeffrey, Katy J McCann, Hayley Simon, Monalisa Mondal, Alice Wang, Martina Dicker, Elena Lopez-Guadamillas, Ting-Fang Chou, Nicola A Dobbs, Louisa Essame, Gary Acton, Fiona Kelly, Gavin Halbert, Joseph J Sacco, Andrew Graeme Schache, Richard J Shaw, James Anthony McCaul, Claire Paterson, Joseph H Davies, Peter A Brennan, Rabindra P Singh, Paul M Loadman, William Wilson, Allan Hackshaw, Grégory Seumois, Klaus Okkenhaug, Gareth J Thomas, Terry M Jones, Ferhat Ay, Greg Friberg, Mitchell Kronenberg, Bart Vanhaesebroeck, Pandurangan Vijayanand, Christian Hermann Ottensmeier
Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs. Nature 605 (7911) (2022)
Roger M Phillips, Paul M Loadman, Guru Reddy
Inactivation of apaziquone by haematuria: implications for the design of phase III clinical trials against non-muscle invasive bladder cancer. Cancer chemotherapy and pharmacology 83 (6) (2019)

Paul M Loadman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Paul M Loadman